Acupoint injection of ganglioside for children with spastic cerebral palsy

Abstract

Objective To analyze and investigate the clinical efficacy of acupoint injection of ganglioside for children with spastic cerebral palsy. Methods 92 children with spastic cerebral palsy treated at hospital from April, 2015 to April, 2017 were selected and divided into an observation group (46 cases) and a control group (46 cases). The control group took routine rehabilitation training; in addition, the observation group were treated with acupoint injection of gangliosides. The clinical effects, adverse reactions, and changes of correlation scores (CSS, ADL, and GMFM) of the two groups were observed and compared. Results After the appropriate treatment, the total effective rate was 87.0% in the observation group and was 67.4% in the control group (P < 0.05). After the treatment, the scores of CSS, ADL, and GMFM were all significantly improved in the two groups (P < 0.05) and were better in the observation group than in the control group (P < 0.05). No obvious adverse reactions occurred during the treatment in both groups. Conclusions Acupoint injection of ganglioside for children with spastic cerebral palsy can achieve good results, significantly improve the state of limb spasticity and the patients' prognosis, and promote the recovery of motor ability and daily living ability and has a positive clinical implication. Key words: Ganglioside; Pediatric spastic cerebral palsy; Effect; Motor ability; Daily living ability